Q32 Bio Inc. (QTTB)
(Delayed Data from NSDQ)
$45.29 USD
-2.17 (-4.57%)
Updated Nov 8, 2024 04:00 PM ET
After-Market: $45.30 +0.01 (0.02%) 7:58 PM ET
4-Sell of 5 4
F Value D Growth D Momentum F VGM
Q32 Bio (QTTB) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$84.00 | $100.00 | $54.00 | 76.99% |
Price Target
Based on short-term price targets offered by six analysts, the average price target for Q32 Bio comes to $84.00. The forecasts range from a low of $54.00 to a high of $100.00. The average price target represents an increase of 76.99% from the last closing price of $47.46.
Analyst Price Targets (6 )
Broker Rating
Q32 Bio currently has an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by six brokerage firms. The current ABR compares to an ABR of 1.00 a month ago based on five recommendations.
Of the six recommendations deriving the current ABR, six are Strong Buy, representing 100% of all recommendations. A month ago, Strong Buy represented 100%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 6 | 6 | 5 | 5 | 4 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
11/7/2024 | SVB Securities | Thomas J Smith | Strong Buy | Strong Buy |
10/23/2024 | Not Identified | Not Identified | Not Available | Strong Buy |
9/11/2024 | Wells Fargo Securities | Derek C Archila | Not Available | Strong Buy |
8/12/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
6/17/2024 | Guggenheim Securities | Yatin Suneja | Not Available | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.00 |
ABR (Last week) | 1.00 |
# of Recs in ABR | 6 |
Average Target Price | $86.33 |
LT Growth Rate | NA |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 77 of 252 |
Current Quarter EPS Est: | -1.53 |
QTTB FAQs
Q32 Bio Inc. (QTTB) currently has an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 6 brokerage firms.
The average price target for Q32 Bio Inc. (QTTB) is $86.33. The current on short-term price targets is based on 4 reports.
The forecasts for Q32 Bio Inc. (QTTB) range from a low of $68 to a high of $100. The average price target represents a increase of $90.62 from the last closing price of $45.29.
The current UPSIDE for Q32 Bio Inc. (QTTB) is 90.62%
Based on short-term price targets offered by six analysts, the average price target for Q32 Bio comes to $84.00. The forecasts range from a low of $54.00 to a high of $100.00. The average price target represents an increase of 76.99% from the last closing price of $47.46.